Akèy › Kansè san › Colorado › Denver
Etid klinik pou Kansè san nan Denver, CO
9 etid pou Kansè san ap chèche patisipan nan sit nan ak bò kote Denver (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Ap rekriteFaz 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- AdventHealth Porter, Denver
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Ap rekriteFaz 3
- CBCI, Colorado Blood Cancer Institute, Denver
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Ap rekriteFaz 3
- Colorado Blood Cancer Institute, Denver
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- Colorado Blood Cancer Institute, Denver
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Ap rekriteFaz 1
- Colorado Blood Cancer Institute, Denver
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- Colorado Blood Cancer Institute, Denver
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- Children's Hospital Colorado, Denver
Etid Kansè san nan lòt vil
- Houston, TX46 etid
- New York City, NY26 etid
- Boston, MA25 etid
- Washington, DC19 etid
- Seattle, WA18 etid
- Baltimore, MD18 etid
- Los Angeles, CA17 etid
- Durham, NC16 etid
- Chicago, IL15 etid
- Philadelphia, PA14 etid
- Columbus, OH13 etid
- Edison, NJ13 etid
Lòt etid nan Denver
- Kansè Metastatik29 etid
- Kansè nan tete29 etid
- Kansè Poumon ki pa ti selil27 etid
- Myelom Miltip27 etid
- Kansè kolorektal23 etid
- Melanom19 etid
- Kansè pwostat19 etid
- Kansè (tout kalite)18 etid
- Kansè ovè16 etid
- Kansè poumon16 etid
- Kansè Endomèt15 etid
- Limfòm Non-Hodgkin14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.